Advances in apheresis therapy for glomerular diseases

Clinical and Experimental Nephrology

Volumn 11, Issue 2, 2007, Pages 122-127

  Yokoyama, Hitoshi ^a   Wada, Takashi ^b   Zhang, Wei ^a   Yamaya, Hideki ^a   Asaka, Mitsuhiro ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Apheresis; Glomerulonephritis; Immunomodulation; Nephrotic syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; DEXTRAN SULFATE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GLUCOCORTICOID; METHYLPREDNISOLONE; PHENYLALANINE; PREDNISOLONE; PROTEIN A; TRYPTOPHAN;

ANCA ASSOCIATED VASCULITIS; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; APHERESIS; CLINICAL TRIAL; CYTAPHERESIS; GLOMERULONEPHRITIS; GLOMERULOPATHY; HUMAN; HYPERLIPIDEMIA; IMMUNOADSORPTION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOMODULATION; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHRITIS; NEPHROTIC SYNDROME; PATHOGENICITY; PLASMAPHERESIS; PROTEINURIA; REVIEW; STEROID THERAPY; T LYMPHOCYTE;

BLOOD COMPONENT REMOVAL; GLOMERULONEPHRITIS; HUMANS; LEUKAPHERESIS; NEPHROTIC SYNDROME; PLASMA EXCHANGE; PLASMAPHERESIS;

EID: 34347341617     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-007-0462-y     Document Type: Review

References (37)

1. CM Lockwood JJ Boulton RM Lowenthal IJ Simpson DK Peters 1975 Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis BMJ 2 252 4
2. T Agishi 2002 Birth of the concept and the development of extracorporeal immunomodulation Ther Apher 6 312 6
3. A Koyama M Fujisaki M Kobayashi M Igarashi M Narita 1991 A glomerular permeability factor produced by human T cell hybridomas Kidney Int 40 453 60
4. Y Godfrin J Dantal JF Bouhours JM Heslan JP Soulillou 1996 A new method of measuring albumin permeability in isolated glomeruli Kidney Int 50 1352 7
5. VJ Savin R Sharma M Sharma ET McCarthy SK Swan E Ellis 1996 Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis N Engl J Med 334 878 83
6. J Dantal E Bigot W Bogers A Testa F Kriaa Y Jacques 1994 Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome N Engl J Med 330 7 14
7. M Haas Y Godfrin R Oberbauer N Yilmaz K Borchhardt H Regele 1998 Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis Nephrol Dial Transplant 13 2013 6
8. J Dantal Y Godfrin R Koll S Perretto J Naulet JF Bouhours JP Soulillou 1998 Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome J Am Soc Nephrol 9 1709 15
9. ML Artero R Sharma VJ Savin F Vincenti 1994 Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis Am J Kidney Dis 23 574 81
10. SM Feld Figueroa V Savin CC Nast R Sharma M Sharma 1998 Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys Am J Kidney Dis 32 230 7
11. E Muso M Yashiro M Matsushima H Yoshida K Sawanishi S Sasayama 1994 Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant 9 257 64
12. H Yokoyama M Shimizu T Wada K Yoshimoto Y Iwata K Shimizu 2002 The beneficial effects of lymphocytapheresis for treatment of nephrotic syndrome Ther Apher 6 167 73
13. A Yagishita K Kikuchi 2002 Apheresis of immune diseases and apheresis using immunological specificity Ther Apher 6 358 64
14. F Madore JM Lazarus H Brady 1996 Therapeutic plasma exchange in renal diseases J Am Soc Nephrol 7 367 86
15. JP Johnson JJ Moore HB Austin JE Balow TT Antnovych CB Wilson 1985 Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors Medicine (Baltimore) 64 219 27
16. G Gaskin CD Pusey 2001 Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis Ther Apher 5 176 81
17. WM Glöckner HG Sieberth HE Wichmann E Backes R Bambauer WH Boesken 1988 Plasma exchange and immunosuppression in rapidly progressive nephritis: a controlled, multi-center study Clin Nephrol 29 1 8
18. CD Pusey AJ Rees DJ Evans DK Petters CM Lockwood 1991 Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies Kidney Int 40 757 63
19. G Rifle E Dechelette 1990 Treatment of rapidly progressive glomerulonephritis by plasma exchange and methylprednisolone pulses. A prospective randomized trial of cyclophosphamide. Interim analysis. The French Cooperative Group Prog Clin Biol Res 337 263 7
20. JM Mauri MT Gonzales R Poveda 1985 Therapeutic plasma exchange in the treatment of rapidly progressive glomerulonephritis Plasma Ther Transfus Technol 6 587 91
21. E Cole D Cattran A Magil C Greenwood D Churchill D Sutton the Canadian Apheresis Study Group 1992 A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group Am J Kidney Dis 20 261 9
22. RAF de Lind van Wijngaarden HA Hauer R Wolterbeek DRW Jayne G Gaskin N Rasmussen 2006 The European Vasculitis Study Group (EUVAS). Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement J Am Soc Nephrol 17 2264 74
23. N Mistry-Burchardi U Schönermarck W Samtleben 2001 Apheresis in lupus nephritis Ther Apher 5 161 70
24. EJ Lewis LG Hunsicker SP Lan RD Rohde JM Lachin 1992 A controlled trial of plasmapheresis therapy in severe lupus nephritis N Engl J Med 326 1373 9
25. DJ Wallace D Goldfinger SH Pepkowitz M Fichman AL Metzger JO Schroeder HH Euler 1998 Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis J Clin Apheresis 13 163 6
26. D Taube Z Brown DG Williams 1984 Impaired lymphocyte and suppressor cell function in minimal change nephropathy, membranous nephropathy and focal glomerulosclerosis Clin Nephrol 22 176 82
27. H Yokoyama H Kida Y Tani T Abe N Tomosugi Y Koshino N Hattori 1985 Immunodynamics of minimal change nephrotic syndrome in adults: T and B lymphocyte subsets and serum immunoglobulin levels Clin Exp Immunol 61 601 7
28. M Sharma R Sharma ET McCarthy VJ Savin 1999 "The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma J Am Soc Nephrol 10 552 61
29. RY Gohh AF Yango PE Morrissey AP Monaco A Gautam M Sharma 2005 Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients Am J Transplant 5 2907 12
30. T Bosch T Wendler 2001 Extracorporeal plasma treatment in primary and recurrent focal segmental glomerular sclerosis: a review Ther Apher 5 155 60
31. K Yokoyama S Sakai T Sigematsu F Takemoto S Hara A Yamada 1998 LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy Clin Nephrol 50 1 7
32. K Yokoyama S Sakai Y Yamaguchi Y Suzuki F Hinoshita S Hara 1996 Complete remission of the nephrotic syndrome due to focal glomerular sclerosis achieved with low density lipoprotein adsorption alone Nephron 72 318 20
33. P Stenvinkel A Alvestrand B Angelin M Eriksson 2000 LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion Eur J Clin Invest 30 866 70
34. Y Takenaka 1996 Lymphocytapheresis Artif Organs 20 914 6
35. T Bosch 2005 Therapeutic apheresis - state of the art in the year 2005 Ther Apher Dial 9 459 68
36. T Furuta O Hotta N Yusa I Horigome S Chiba Y Taguma 1998 Lymphocytapheresis to treat rapidly progressive glomerulonephritis: a randomised comparison with steroid-pulse treatment Lancet 352 203 4
37. M Hasegawa A Watanabe H Takahashi K Takahashi M Kasugai N Kawamura 2005 Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors Ther Apher Dial 9 297 302